CareDx (CDNA) Reports In-Line Q3 EPS

CareDx (NASDAQ: CDNA) reported Q3 EPS of ($0.06), in-line with the analyst estimate of ($0.06). Revenue for the quarter came in at $53.4 million versus the consensus estimate of $53.01 million.

For earnings history and earnings-related data on CareDx (CDNA) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Can global equities keep rising? UBS sees these factors driving upside
• Is the S&P 500 in an "earnings bubble"? Goldman weighs in